Search Thermo Fisher Scientific
A suggested positive control is rat liver tissue lysate.
PA5-20895 can be used with blocking peptide PEP-1009.
Alzheimers disease (AD) is a progressive neurodegenerative disorder characterized by a massive loss of neurons in several brain regions and by the presence of senile plaques comprised of aggregated amyloid-beta (Abeta) peptides produced by the endoproteolysis of the amyloid precursor protein (APP). The calcium homeostasis modulator 1 (CALHM1) is a recently identified multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentration and Abeta levels. While some studies suggest CALHM1 is significantly associated with risk of AD, other reports suggest there is no link. CALHM1 has been suggested to modulate the Ca2+-dependent proteolytic process of APP through controlling the level of cytosolic Ca2+.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Calcium homeostasis modulator protein 1; family with sequence similarity 26, member C; Protein FAM26C
基因别名: CALHM1; EG546729; FAM26C; RGD1564891
UniProt ID: (Human) Q8IU99, (Mouse) D3Z291
Entrez Gene ID: (Human) 255022, (Rat) 499367, (Mouse) 546729